Brandon BioCatalyst
Venture capitalMelbourne · Pre-Seed–Series A · 1 people tracked
Investment thesis
Brandon BioCatalyst, managed by Brandon Capital, focuses on early-stage life science and biomedical innovation originating from a network of more than 50 medical research institutes and hospitals across Australia and New Zealand. Backed by investors, CSL, superannuation funds and government partners, it provides seed and venture capital alongside commercialisation expertise to develop next-generation medical therapies and technologies. The aim is to guide promising biomedical discoveries from research through to successful commercial development and international growth, ultimately improving health outcomes and saving lives.
Source: firm website, verified Jul 31, 2026.
Team · 1 people
from the firm's websiteHandles media inquiries for Brandon BioCatalyst.
Investments · 7 tracked
founders shown can be your intro pathCommenced a Phase I safety study in patients with early Alzheimer's disease.
Developing novel non-absorbable, orally-delivered polymers for the treatment of Type 2 Diabetes.
Developing a Quantitative Micro-Elastography (QME) imaging system, Elora; closed an AUD $27M private funding round.
Clinical-stage biotech developing Q-122, an orally bioavailable small molecule for treating endocrine therapy-induced hot flashes in breast cancer patients.
Frequently asked questions
- What stage does Brandon BioCatalyst invest at?
- Brandon BioCatalyst invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Brandon BioCatalyst focus on?
- Brandon BioCatalyst focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Brandon BioCatalyst located?
- Brandon BioCatalyst is headquartered in Melbourne, AU.
- Does Brandon BioCatalyst lead rounds?
- Yes, Brandon BioCatalyst leads investment rounds.
Similar investors
Amadeus Capital Partners is a technology investor. It held a first close of $75M on its Amadeus IV Digital Prosperity Fund, focused on late-stage venture and growth companies building online and mobile services for emerging-market middle classes.
B Capital Group is a multistage venture capital firm that invests from seed to late stage, offering value-added support to founders in partnership with management consulting firm BCG.
Breyer Capital is a venture capital firm founded and led by Jim Breyer, headquartered in Austin, Texas, focused on long-term entrepreneurs in AI, quantum technology, and computation-driven healthcare and life sciences.
DCVC (Data Collective) is a deep tech venture capital firm backing entrepreneurs using computational approaches to solve large real-world problems across many industries. It operates six flagship funds plus DCVC Bio, spanning 13 funds to date.
Innovestor is a Finland-based investment group active in venture capital, life science and health, technology, real estate, and energy storage, also offering angel co-investment and corporate venturing services.